These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 23314623)

  • 1. Health- and vision-related quality of life in patients receiving infliximab therapy for Behcet uveitis.
    Sakai T; Watanabe H; Kuroyanagi K; Akiyama G; Okano K; Kohno H; Tsuneoka H
    Br J Ophthalmol; 2013 Mar; 97(3):338-42. PubMed ID: 23314623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vision- and health-related quality of life in patients with Behçet uveitis.
    Onal S; Savar F; Akman M; Kazokoglu H
    Arch Ophthalmol; 2010 Oct; 128(10):1265-71. PubMed ID: 20937995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Behçet's disease: a multicenter study.
    Takeuchi M; Kezuka T; Sugita S; Keino H; Namba K; Kaburaki T; Maruyama K; Nakai K; Hijioka K; Shibuya E; Komae K; Hori J; Ohguro N; Sonoda KH; Mizuki N; Okada AA; Ishibashi T; Goto H; Mochizuki M
    Ophthalmology; 2014 Oct; 121(10):1877-84. PubMed ID: 24950593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration.
    Cahill MT; Stinnett SS; Banks AD; Freedman SF; Toth CA
    Ophthalmology; 2005 Jan; 112(1):144-51. PubMed ID: 15629835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal infliximab for sight-threatening relapsing uveitis in Behçet disease: a pilot study in 15 patients.
    Markomichelakis N; Delicha E; Masselos S; Sfikakis PP
    Am J Ophthalmol; 2012 Sep; 154(3):534-541.e1. PubMed ID: 22789563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet disease.
    Yamada Y; Sugita S; Tanaka H; Kamoi K; Kawaguchi T; Mochizuki M
    Br J Ophthalmol; 2010 Mar; 94(3):284-8. PubMed ID: 19692382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of laser photocoagulation treatment for diabetic macular oedema on patient's vision-related quality of life.
    Tranos PG; Topouzis F; Stangos NT; Dimitrakos S; Economidis P; Harris M; Coleman AL
    Curr Eye Res; 2004 Jul; 29(1):41-9. PubMed ID: 15370366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vitrectomy for epiretinal membrane on visual function and vision-related quality of life.
    Okamoto F; Okamoto Y; Hiraoka T; Oshika T
    Am J Ophthalmol; 2009 May; 147(5):869-74, 874.e1. PubMed ID: 19200531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normative comparison of patient-reported outcomes in patients with noninfectious uveitis.
    Naik RK; Rentz AM; Foster CS; Lightman S; Belfort R; Lowder C; Whitcup SM; Kowalski JW; Revicki DA
    JAMA Ophthalmol; 2013 Feb; 131(2):219-25. PubMed ID: 23411886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
    Tugal-Tutkun I; Mudun A; Urgancioglu M; Kamali S; Kasapoglu E; Inanc M; Gül A
    Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of Life in Patients with Noninfectious Uveitis Treated with or without Systemic Anti-inflammatory Therapy.
    Gui W; Dombrow M; Marcus I; Stowe MH; Tessier-Sherman B; Yang E; Huang JJ
    Ocul Immunol Inflamm; 2015 Apr; 23(2):135-43. PubMed ID: 24867459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responsiveness of Vision-Specific and General Quality of Life Metrics to Ocular and Systemic Events in Patients with Uveitis.
    Sugar EA; Burke AE; Venugopal V; Thorne JE; Holbrook JT;
    Ophthalmology; 2020 Dec; 127(12):1710-1718. PubMed ID: 32717341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease.
    Tabbara KF; Al-Hemidan AI
    Am J Ophthalmol; 2008 Dec; 146(6):845-50.e1. PubMed ID: 18929351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.
    Tognon S; Graziani G; Marcolongo R
    Ann N Y Acad Sci; 2007 Sep; 1110():474-84. PubMed ID: 17911463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
    Galor A; Perez VL; Hammel JP; Lowder CY
    Ophthalmology; 2006 Dec; 113(12):2317-23. PubMed ID: 16996615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vision-related quality of life in patients with bilateral severe age-related macular degeneration.
    Cahill MT; Banks AD; Stinnett SS; Toth CA
    Ophthalmology; 2005 Jan; 112(1):152-8. PubMed ID: 15629836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vision- and health-related quality of life in patients with visual field loss after postchiasmatic lesions.
    Gall C; Lucklum J; Sabel BA; Franke GH
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2765-76. PubMed ID: 19117930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with adalimumab in the treatment of ocular Behçet disease.
    Bawazeer A; Raffa LH; Nizamuddin SH
    Ocul Immunol Inflamm; 2010 Jun; 18(3):226-32. PubMed ID: 20482404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term remission of ocular and extraocular manifestations in Behçet's disease using infliximab.
    Handa T; Tsunekawa H; Yoneda M; Watanabe D; Mukai T; Yamamura M; Iwaki M; Zako M
    Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S58-63. PubMed ID: 21968238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter study of infliximab for refractory uveoretinitis in Behçet disease.
    Okada AA; Goto H; Ohno S; Mochizuki M;
    Arch Ophthalmol; 2012 May; 130(5):592-8. PubMed ID: 22652845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.